Hyperosmolar Solutions Selectively Block Action Potentials in Rat Myelinated Sensory Fibers: Implications for Diabetic Neuropathy

Journal of Neurophysiology

Volumn 91, Issue 1, 2004, Pages 48-56

  Matsuka, Yoshizo ^a   Spigelman, Igor ^a,b  

^a UCLA SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; MANNITOL; SODIUM CHLORIDE; SUCROSE;

AMPLITUDE MODULATION; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ELECTRIC FIELD; ELECTRODE; EVOKED RESPONSE; EXTRACELLULAR CALCIUM; HYPEROSMOLALITY; HYPEROSMOLARITY; HYPERPOLARIZATION; MALE; MYELINATED NERVE; NERVE CONDUCTION; NONHUMAN; PARESTHESIA; PRIORITY JOURNAL; RAT; SENSORY NERVE; SPINAL GANGLION; SPINAL NERVE;

ACTION POTENTIALS; ANIMALS; CALCIUM; CHELATING AGENTS; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EGTAZIC ACID; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; GANGLIA, SPINAL; GLUCOSE; MALE; MANNITOL; MEMBRANE POTENTIALS; NERVE FIBERS, MYELINATED; NEURAL CONDUCTION; OSMOLAR CONCENTRATION; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE; SUCROSE; TIME FACTORS;

EID: 0345827440     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.00689.2003     Document Type: Article

References (67)

1. Arezzo JC. New developments in the diagnosis of diabetic neuropathy. Am J Med 107: 9S-16S, 1999.
2. Arieff AI and Carroll HJ. Nonketotic hyperosmolar coma with hyperglycemia: clinical features, pathophysiology, renal function, acid-base balance, plasma-cerebrospinal fluid equilibria and the effects of therapy in 37 cases. Medicine (Baltimore) 51: 73-94, 1972.
3. Benbow SJ, Cossins L, and MacFarlane IA. Painful diabetic neuropathy. Diabet Med 16: 632-644, 1999.
4. 2+ current in the action potentials of nociceptive sensory neurons. J Neurosci 22: 10277-10290, 2002.
5. Boulton AJM, Knight G, Drury J, and Ward JD. The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population. Diabetes Care 8: 125-128, 1985.
6. Brismar T. Effects of ionic concentration on permeability properties of nodal membrane in myelinated nerve fibres of Xenopus laevis. Potential clamp experiments. Acta Physiol Scand 87: 474-484, 1973.
7. Brismar T. Neuropathy-functional abnormalities in the BB rat. Metabolism 32: 112-117, 1983.
8. Brismar T. Abnormal Na-currents in diabetic rat nerve nodal membrane. Diabet Med 10: S110-S112, 1993.
9. Brismar T and Sima AAF. Changes in nodal function in nerve-fibers of the spontaneously diabetic BB-Wistar rat-potential clamp analysis. Acta Physiol Scand 113: 499-506, 1981.
10. Brismar T, Sima AAF, and Greene DA. Reversible and irreversible nodal dysfunction in diabetic neuropathy. Ann Neurol 21: 504-507, 1987.
11. Celiker R, Basgoze O, and Bayraktar M. Early detection of neurological involvement in diabetes mellitus. Electromyogr Clin Neurophysiol 36: 29-35, 1996.
12. +-channel displacement is associated with nerve-conduction slowing in the chronically diabetic BB/W rat: prevention by aldose reductase inhibition. J Diabetes Complications 10: 192-200, 1996.
13. Das PK, Bray GM, Aguayo AJ, and Rasminsky M. Diminished ouabain-sensitive, sodium-potassium ATPase activity in sciatic-nerves of rats with streptozotocin-induced diabetes. Exp Neurol 53: 285-288, 1976.
14. De Koninck Y and Henry JL. Peripheral vibration causes an adenosine-mediated postsynaptic inhibitory potential in dorsal horn neurons of the cat spinal cord. Neuroscience 50: 435-443, 1992.
15. Dobretsov M, Hastings SL, Romanovsky D, Stimers JR, and Zhang JM. Mechanical hyperalgesia in rat models of systemic and local hyperglycemia. Brain Res 960: 174-183, 2003.
16. Dobretsov M, Hastings SL, Stimers JR, and Zhang JM. Mechanical hyperalgesia in rats with chronic perfusion of lumbar dorsal root ganglion with hyperglycemic solution. J Neurosci Methods 110: 9-15, 2001.
17. Downie AW and Newell DJ. Sensory nerve conduction in patients with diabetes mellitus and controls. Neurology 11: 876-882, 1961.
18. Elias KA, Cronin MJ, Stewart TA, and Carlsen RC. Peripheral neuropathy in transgenic diabetic mice: restoration of C-fiber function with human recombinant nerve growth factor. Diabetes 47: 1637-1642, 1998.
19. Elliott AA and Elliott JR. Characterization of TTX-sensitive and TTX-resistant sodium currents in small cells from adult rat dorsal root ganglia. J Physiol 463: 39-56, 1993.
20. Fozzard HA and Lee CO. Influence of changes in external potassium and chloride ions on membrane potential and intracellular potassium ion activity in rabbit ventricular muscle. J Physiol 256: 663-689, 1976.
21. Fulop M, Tannenbaum H, and Dreyer N. Ketotic hyperosmolar coma. Lancet 2: 635-639, 1973.
22. Gamble HJ. Comparative electron-microscopic observations on the connective tissues of a peripheral nerve and a spinal root in the rat. J Anat 98: 17-25, 1964.
23. Gerich JE, Martin MM, and Recant L. Clinical and metabolic characteristics of hyperosmolar nonketotic coma. Diabetes 20: 228-238, 1971.
24. Gilliatt RW and Willison RG. Peripheral nerve conduction in diabetic neuropathy. J Neurol Neurosurg Psychiatry 25: 11-18, 1962.
25. +-ATPase, conduction, and myoinositol in the insulin-deficient BB rat. Am J Physiol 247: E534-E539, 1984.
26. Harper AA and Lawson SN. Conduction velocity is related to morphological cell type in rat dorsal root ganglion neurones. J Physiol 359: 31-46, 1985a.
27. Harper AA and Lawson SN. Electrical properties of rat dorsal root ganglion neurones with different peripheral nerve conduction velocities. J Physiol 359: 47-63, 1985b.
28. Hille B. Charges and potentials at the nerve surface. Divalent ions and pH. J Gen Physiol 51: 221-236, 1968.
29. Hille B. The superfamily of voltage-gated channels. In: Ion Channels of Excitable Membranes, edited by Hille B. Sunderland: Sinauer, 2001, p. 61-93.
30. Hoffman RP, Hausberg M, Sinkey CA, and Anderson EA. Hyperglycemia without hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Diabetes Complications 13: 17-22, 1999.
31. Horowitz SH. Diabetic neuropathy. Clin Orthop 78-85, 1993.
32. Hyllienmark L, Brismar T, and Ludvigsson J. Subclinical nerve dysfunction in children and adolescents with IDDM. Diabetologia 38: 685-692, 1995.
33. Hyllienmark L, Ludvigsson J, and Brismar T. No acute effect of high blood glucose on nerve conduction in adolescents with IDDM. Diabetes Res Clin Pract 35: 157-161, 1997.
34. Imam I, Salako BL, and Akinola A. Peripheral neuropathy in Nigerian subjects with chronic renal failure. Niger J Med 12: 72-75, 2003.
35. Junge D. Voltage clamping. In: Nerve and Muscle Excitation, edited by Junge D. Sunderland: Sinauer, 1992, p. 78-96.
36. Koester J. Passive membrane properties of the neuron. In: Principles of Neural Science, edited by Kandel ER, Schwartz JH, and Jessel TM. New York: Elsevier, 1991a, p. 94-103.
37. Koester J. Voltage-gated ion channels and the generation of the action potential. In: Principles of Neural Science, edited by Kandel ER, Schwartz JH, and Jessel TM. New York: Elsevier, 1991b, p. 104-118.
38. Kostyuk PG, Veselovsky NS, and Tsyndrenko AY. Ionic currents in the somatic membrane of rat dorsal root ganglion neurons. 1. sodium currents. Neuroscience 6: 2423-2430, 1981.
39. LaMotte RH, Lundberg LE, and Torebjork HE. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin. J Physiol 448: 749-764, 1992.
40. Mahoney CA and Arieff AI. Central and peripheral nervous system effects of chronic renal failure. Kidney Int 24: 170-177, 1983.
41. Mettang T, Pauli-Magnus C, and Alscher DM. Uraemic pruritus-new perspectives and insights from recent trials. Nephrol Dial Transplant 17: 1558-1563, 2002.
42. Moore JW and Cox EB. A kinetic model for the sodium conductance system in squid axon. Biophys J 16: 171-192, 1976.
43. Moore SA, Peterson RG, Felten DL, and Oconnor BL. A quantitative comparison of motor and sensory conduction velocities in short- and long-term streptozotocin- and alloxan-diabetic rats. J Neurol Sci 48: 133-152, 1980.
44. Mulder DW, Lambert EH, Bastron JA, and Sprague RG. The neuropathies associated with diabetes mellitus. Neurology 11: 275-284, 1961.
45. Muravitskaia OS, Nevenglovskii IE, Smirnova VA, and Rumiantsev VB. The osmolarity of the blood and urine in patients with tuberculosis of the urinary system and chronic kidney failure. Urol Nefrol (Mosk) 1: 19-22, 1990.
46. Murphy M and Carmichael AJ. Renal itch. Clin Exp Dermatol 25: 103-106, 2000.
47. Ochoa JL and Yarnitsky D. The triple cold syndrome. Cold hyperalgesia, cold hypoaesthesia and cold skin in peripheral nerve disease. Brain 117: 185-197, 1994.
48. Ogura T, You YD, and McDonald TF. Membrane currents underlying the modified electrical activity of guinea-pig ventricular myocytes exposed to hyperosmotic solution. J Physiol 504: 135-151, 1997.
49. Oomura Y, Ooyama H, Sugimori M, Nakamura T, and Yamada Y. Glucose inhibition of the glucose-sensitive neurone in the rat lateral hypothalamus. Nature 247: 284-286, 1974.
50. Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, and Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 333: 89-94, 1995.
51. Patel J and Tomlinson DR. Nerve conduction impairment in experimental diabetes-proximodistal gradient of severity. Muscle Nerve 22: 1403-1411, 1999.
52. Quasthoff S. The role of axonal ion conductances in diabetic neuropathy: a review. Muscle Nerve 21: 1246-1255, 1998.
53. Schmeichel AM, Schmelzer JD, and Low PA. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 52: 165-171, 2003.
54. Shanthaveerappa TR and Bourne GH. Perineural epithelium: a new concept of its role in the integrity of the peripheral nervous system. Science 154: 1464-1467, 1966.
55. Sharma AK and Thomas PK. Peripheral nerve structure and function in experimental diabetes. J Neurol Sci 23: 1-15, 1974.
56. Shinder V and Devor M. Structural basis of neuron-to-neuron cross-excitation in dorsal root ganglia. J Neurocytol 23: 515-531, 1994.
57. Silver IA and Erecinska M. Extracellular glucose concentration in mammalian brain: continuous monitoring of changes during increased neuronal activity and upon limitation in oxygen supply in normo-, hypo-, and hyperglycemic animals. J Neurosci 14: 5068-5076, 1994.
58. Silver IA and Erecinska M. Glucose-induced intracellular ion changes in sugar-sensitive hypothalamic neurons. J Neurophysiol 79: 1733-1745, 1998.
59. Spigelman I, Gold MS, and Light AR. Electrophysiological recording techniques in pain research. In: Methods in Pain Research, edited by Kruger L. Boca Raton: CRC, 2001, p. 147-168.
60. Srinivasan S, Stevens M, and Wiley JW. Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction. Diabetes 49: 1932-1938, 2000.
61. Stys PK, Ransom BR, and Waxman SG. Compound action potential of nerve recorded by suction electrode: a theoretical and experimental analysis. Brain Res 546: 18-32, 1991.
62. Villière V and McLachlan EM. Electrophysiological properties of neurons in intact rat dorsal root ganglia classified by conduction velocity and action potential duration. J Neurophysiol 76: 1924-1941, 1996.
63. Vinik AI, Park TS, Stansberry KB, and Pittenger GL. Diabetic neuropathies. Diabetologia 43: 957-973, 2000.
64. Wachtel TJ, Tetu-Mouradjian LM, Goldman DL, Ellis SE, and O'Sullivan PS. Hyperosmolarity and acidosis in diabetes mellitus: a three-year experience in Rhode lsland. J Gen Intern Med 6: 495-502, 1991.
65. Wahren LK, Torebjork E, and Jorum E. Central suppression of cold-induced C fibre pain by myelinated fibre input. Pain 38: 313-319, 1989.
66. Winkler AS, Ejskjaer N, Edmonds M, and Watkins PJ. Dissociated sensory loss in diabetic autonomic neuropathy. Diabet Med 17: 457-462, 2000.
67. Ziegler D, Gries FA, Spüler M, Lessmann F, and DiaCAN Multicenter Study Group. The epidemiology of diabetic neuropathy. Diabet Med 10: S82-S86, 1993.